The Leadership Team at Galectin Therapeutics is responsible for strategic decision-making and guiding the company's vision to advance innovative therapies targeting galectin proteins for fibrotic diseases and cancer. This team, composed of top executives including the CEO, CFO, and Chief Medical Officer, oversees clinical development, financial health, and operational excellence, ensuring the alignment of scientific endeavors with business objectives to drive the company's growth and mission.
View all